Benefits
Insulin sensitivity and blood sugar markers
In an eight week randomized trial of 39 adults, piceatannol at 20 mg a day did not change the main glucose and insulin sensitivity measures across the whole group. In a subgroup of overweight men it lowered fasting insulin, an insulin resistance score (HOMA-IR), blood pressure and heart rate, while women and normal-weight participants saw no change. The trial was funded by the ingredient's maker.
Antioxidant and free radical scavenging activity
In cell and chemical studies piceatannol neutralizes reactive oxygen species and raises cellular glutathione, and it scavenges free radicals in test tube assays. In the one human trial that measured blood markers of oxidative stress, piceatannol did not change them, so the laboratory antioxidant activity has not yet been confirmed in people.
SIRT1 activity and metabolic signaling
SIRT1 is a cellular enzyme involved in energy and fat handling. In muscle cell studies piceatannol raised SIRT1 and switched on genes for mitochondrial activity and fat use, more than resveratrol did. In a two week trial, adults taking 100 mg a day had higher SIRT1 gene activity in blood than placebo. This is a laboratory marker, not a measured health outcome.
Skin moisture and the look of fine lines
Two small trials in Japanese women used passion fruit seed extract supplying 5 or 10 mg of piceatannol a day for eight weeks. Facial skin moisture rose compared with placebo, and in the larger trial wrinkle grades improved. Both trials were run by the ingredient's maker and measured skin readings over a short period.
Fat handling and energy pathways in cell and animal work
In mice on a high fat diet, piceatannol by mouth improved glucose tolerance and raised liver SIRT1 and insulin signaling proteins, matching or beating resveratrol in the same study. Cell work shows it lowers fat buildup and promotes mitochondrial activity. These are animal and cell results that have not been reproduced as outcomes in people.
Mechanism of action
Stilbene structure with an added hydroxyl group
Piceatannol is a hydroxylated analog of resveratrol with one more hydroxyl group on its stilbene backbone. In laboratory assays this extra group contributes to its antioxidant and free radical scavenging activity.
SIRT1 and AMPK energy sensors
In cell and animal studies piceatannol raises SIRT1 and activates AMPK, pathways linked to mitochondrial activity and fat metabolism. A human trial found higher SIRT1 gene activity in whole blood, but another found no change in SIRT1 or AMPK in isolated immune cells, so the effect in people is uncertain.
Reactive oxygen species and glutathione
In skin cell studies piceatannol raised glutathione levels and suppressed the reactive oxygen species generated by UVB light. These are cell findings that describe how it might protect tissue, not measured outcomes in people.
Rapid metabolism and limited human data
Laboratory work shows piceatannol is rapidly processed in the liver, mainly to a glucuronide conjugate with some sulfation. Its absorption, blood levels and effective dose in people are not well defined, which is a main gap in the human evidence.
Clinical trials
Eight week randomized, placebo-controlled crossover trial of piceatannol 20 mg a day on glucose metabolism and related markers, funded by the ingredient's maker. (Kitada et al. 2017, Nutrients)
39 adults: 10 overweight men, 9 overweight women, 10 non-overweight men and 10 non-overweight women.
The main glucose and insulin sensitivity outcomes did not improve across the whole group. In the subgroup of overweight men, piceatannol lowered fasting insulin, HOMA-IR, blood pressure and heart rate; women and non-overweight participants showed no change. Oxidative stress, lipids, inflammation, endothelial function and immune-cell SIRT1 and AMPK were unchanged.
Eight week randomized, double-blind, placebo-controlled trial of passion fruit seed extract supplying 5 mg a day of piceatannol in women with dry skin, run by the ingredient's maker. (Maruki-Uchida et al. 2018, J Nutr Sci Vitaminol)
32 healthy Japanese women aged 35 to 54 with dry skin.
Facial skin moisture rose within the extract group at 4 and 8 weeks, and was higher than placebo in a subgroup with the driest skin. Transepidermal water loss fell but not significantly. Questionnaire ratings of perspiration and fatigue improved versus placebo. A short trial of skin readings in a small group.
Muscle cell experiments plus a randomized, double-blind, placebo-controlled trial of a food containing 100 mg piceatannol for 2 weeks, run by the ingredient's maker. (Tanaka et al. 2024, Life (Basel))
C2C12 muscle cells, and adults of varying age and body mass index in the human part.
In muscle cells piceatannol raised SIRT1 and genes for mitochondrial activity and fat use more than resveratrol, and reduced fat accumulation. In the human part, SIRT1 gene activity in whole blood was higher with piceatannol than placebo. These are laboratory markers, not health outcomes.
Eight week randomized, double-blind, placebo-controlled trial of a drink with 10 mg a day of piceatannol from passion fruit seeds, run by the ingredient's maker. (Seto et al. 2026, Front Nutr)
Healthy Japanese women aged 30 to 59; 82 of 86 enrolled were analyzed.
Facial stratum corneum hydration rose significantly versus placebo, and wrinkle grades improved significantly versus placebo. The trial measured skin readings over eight weeks and was run by the ingredient's maker.